Sophia-Antipolis, France

Press release – For immediate release– 05:45 pm CEST

Median Technologies reschedules its Corporate Update webcasts on May 4, 2023

Median Technologies (ALMDT:PA) announced today that the two webcasts during which Fredrik Brag, CEO and Founder will provide a corporate update, are rescheduled from May 3rd to May 4th, 2023. New registration links are below.

Webcast replays will be available on Median’s corporate website after the live sessions.

Download 20230425_PR_Webcasts_reschedule_EN.pdf

About Median Technologies

Pioneering in innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to elevate the accuracy of early cancer diagnoses and cancer treatments. Median’s offerings, including iCRO for medical image analysis and management in oncology trials and eyonis™, AI/ML tech-based suite of software as medical devices (SaMD), empower biopharmaceutical entities and clinicians to advance patient care and expedite novel therapies. The French-based company, with a presence in the U.S. and China is listed  on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for the French SME equity savings plan scheme (PEA-PME).

Contacts

Median Technologies
Emmanuelle Leygues
Head of Corporate Marketing and Financial Communications
+33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com

Press – ALIZE RP
Caroline Carmagnol
+33 6 64 18 99 59
median@alizerp.com

Investors – ACTIFIN
Ghislaine Gasparetto
+33 6 21 10 49 24
ghislaine.gasparetto@seitosei-actifin.com